Reckitt Benckiser Group

Reckitt Benckiser Group develops, acquires, produces, distributes and promotes consumer products in the health, hygiene and home categories. Co.'s health category covers treatment products such as pain and flu, and also wellness products in sexual wellbeing, footcare, vitamins and supplements. Co.'s hygiene category consists of personal and home hygiene products. Co.'s geographical segments comprise Europe (ENA) and Africa, Middle East (DvM). ENA comprises Europe, Russia/CIS, Israel, North America, Australia and New Zealand. DvM principally comprises North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, South Korea and ASEAN.
  • TickerRB.
  • ISINGB00B24CGK77
  • ExchangeLondon Stock Exchange
  • SectorHousehold Goods & Home Construction
  • CountryUnited Kingdom

Reckitt Benckiser Group Plc: Strong first-half performance and improved outlook bode well for leverage

The increase in profit and the better outlook are credit positive and the performance, if sustained in the second half, will result in improving debt metrics.

Virginie Roumage

RECKITT BENCKISER | BUY | GBP9000 Benefitting from COVID-19

RECKITT BENCKISER | BUY | GBP9000 Benefitting from COVID-19 Better on all fronts Health: Dettol and Airborne driving the growth Hygiene-Home: skyrocketing Outlook: clarifications

Virginie Roumage

SECTOR UPDATE | Food & HPC | COVID-19: a plus or a minus

SECTOR UPDATE | Food & HPC | COVID-19: a plus or a minus Reckitt Benckiser | Buy vs Neutral | FV revised upwards to GBP90. Henkel | Neutral unchanged | FV upgraded to EUR93

Reckitt Benckiser Group Plc - December 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Expert Corporate Governance Service (ECGS)

Reckitt Benckiser – AGM 12 May 2020

Item 2: Remeneration report   ECGS seriously questions the work of the Remuneration Committee: it downwards Rakesh Kapoorns bonus to zero considering the quality of earnings, the shareholder experience and the performance of Mead Johnson Nutrition mto ensure it better reflected this overall performance of the Company, during the Company, during 2019'. Despite a £5bn write-off and £898m fine, the Committee only cut Mr. Kapoorns bonus of 12%. No malus or clawback was applied. However, since his appointment in 2011, Mr. Kapoor received £97.6m plus the estimated value of his share outstanding of...

Matthieu DRIOL

Analyse court terme - RECKITT BENCKISER : La tendance est incertaine.

La tendance est incertaine. Les cours baissent, et il y a une possibilité d'accélération baissière. Une nouvelle tendance baissière tente de démarrer.

Matthieu DRIOL

Short term view - RECKITT BENCKISER : The trend is uncertain.

The trend is uncertain. Prices are falling and they may accelerate to the downside. A new bearish trend is attempting to emerge.

Matthieu DRIOL

Analyse court terme - RECKITT BENCKISER : La tendance est incertaine.

La tendance est incertaine. Les cours baissent, mais la tendance manque de puissance pour le moment. Le prochain support est à 6 423,00 p.

Matthieu DRIOL

Short term view - RECKITT BENCKISER : The trend is uncertain.

The trend is uncertain. Prices are falling, but the trend is lacking power for the time being. The next support is at 6,423.00 p.

Jérôme VINERIER

Medium term view - RECKITT BENCKISER : The background trend is clearly bullish.

The background trend is clearly bullish. Prices are still making progress. The following targets are at 7,096.00 p and 7,912.00 p. The trend would be invalidated below the support at 5,090.00 p.

Reckitt Benckiser Group: 1 director bought

A director at Reckitt Benckiser Group bought 10,000 shares at 5,580p and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names ...

Virginie Roumage

RECKITT BENCKISER | BUY | GBP9000 Benefitting from COVID-19

RECKITT BENCKISER | BUY | GBP9000 Benefitting from COVID-19 Better on all fronts Health: Dettol and Airborne driving the growth Hygiene-Home: skyrocketing Outlook: clarifications

Virginie Roumage

SECTOR UPDATE | Food & HPC | COVID-19: a plus or a minus

SECTOR UPDATE | Food & HPC | COVID-19: a plus or a minus Reckitt Benckiser | Buy vs Neutral | FV revised upwards to GBP90. Henkel | Neutral unchanged | FV upgraded to EUR93

Valens Research

UAFRS vs As Reported Monthly Highlights - 2020 02 29

This month, Valens identified distortions and the corresponding adjustments to correct for those distortions for IRM, STAA, DRI, GWRE, GRMN and RB.:GBR.

Valens Research

UAFRS vs As Reported Weekly Highlights - 2020 02 13

This week, Valens identified distortions and the corresponding adjustments to correct for those distortions for RB.:GBR, BLKB, and HSII.

Virginie Roumage

RECKITT BENCKISER: Cutting our forecasts before the Q4 release | NEUTRAL | GBP6270 vs. GBP6400(+4%)

RECKITT BENCKISER - NEUTRAL | GBP6270 vs. GBP6400(+4%) Cutting our forecasts before the Q4 release Hygiene-Home: a consistent performance despite a stronger P&G Health: another weak quarter Group organic sales to deteriorate in Q4 Neutral reiterated

Reckitt Benckiser Group Plc: Strong first-half performance and improved outlook bode well for leverage

The increase in profit and the better outlook are credit positive and the performance, if sustained in the second half, will result in improving debt metrics.

Reckitt Benckiser Group Plc - December 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Reckitt Benckiser Group Plc: Update following outlook change to negative

Our credit view of Reckitt Benckiser, reflecting increased uncertainty about the ability of the company to delever following the announcement of £2 billion additional investments.

Reckitt Benckiser Group Plc - June 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Reckitt Benckiser Group Plc: Reckitt Benckiser’s $1.4 billion US opiod settlement will reduce free cash flow and slow deleveraging

The settlement with the US DOJ and FTC is credit negative because it will reduce its free cash flow and slow down the reduction of its debt and leverage

An unfavourable environment weighs on RECKITT BENCKISER GP.PLC, which sees a downgrade to Neutral

The independent financial analyst theScreener just requalified the general evaluation of RECKITT BENCKISER GP.PLC (GB), active in the Nondurable Household Products industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date October 4, 2019, the closing price was GBp 6,202.00 and its target price was estimated at GBp 5,578.58.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Expert Corporate Governance Service (ECGS)

Reckitt Benckiser – AGM 12 May 2020

Item 2: Remeneration report   ECGS seriously questions the work of the Remuneration Committee: it downwards Rakesh Kapoorns bonus to zero considering the quality of earnings, the shareholder experience and the performance of Mead Johnson Nutrition mto ensure it better reflected this overall performance of the Company, during the Company, during 2019'. Despite a £5bn write-off and £898m fine, the Committee only cut Mr. Kapoorns bonus of 12%. No malus or clawback was applied. However, since his appointment in 2011, Mr. Kapoor received £97.6m plus the estimated value of his share outstanding of...

Expert Corporate Governance Service (ECGS)

Reckitt Benckiser - AGM 09 May 2019

Item 2: Approve the Remuneration Policy  The changes proposed to the Remuneration Policy, strengthen the alignment between pay and performance.  However, they fall short of addressing the major concerns about the remuneration policy.  In particular, they do not reduce the maximum incentive remuneration, which can exceed 5000% of base salary and is considered grossly excessive.  The maximum bonus of 428% of base salary is well above ECGS guidelines limit of 150% of base salary.  Furthermore, there is no monetary cap on the LTIP awards, though there is a cap in terms of the number of shares whi...

Reckitt Benckiser – Proxinvest Corporate Governance Rating ® : C

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch